-+ 0.00%
-+ 0.00%
-+ 0.00%

Zhitong Finance App News, Hehuang Pharmaceutical (00013.HK) announced that after medical insurance renewal with China's National Health Insurance Administration (NHS), ELUNATE® (ELUNATE®), ORPATHYS® (ORPATYS®), and SULANDA® (SULANDA®) will continue to be included in the new “National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalogue” (National Medical Insurance Drug Catalogue) effective from January 1, 2026. Additionally, TAZVERIK® (TAZVERIK®) was included in the first edition of the National Commercial Health Insurance Innovative Drug Catalogue (Commercial Insurance Innovative Drug Catalogue for short).

Zhitongcaijing·12/08/2025 00:17:04
Listen to the news
Zhitong Finance App News, Hehuang Pharmaceutical (00013.HK) announced that after medical insurance renewal with China's National Health Insurance Administration (NHS), ELUNATE® (ELUNATE®), ORPATHYS® (ORPATYS®), and SULANDA® (SULANDA®) will continue to be included in the new “National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalogue” (National Medical Insurance Drug Catalogue) effective from January 1, 2026. Additionally, TAZVERIK® (TAZVERIK®) was included in the first edition of the National Commercial Health Insurance Innovative Drug Catalogue (Commercial Insurance Innovative Drug Catalogue for short).